Candidate antigens for a ductal carcinoma in situ vaccine, essential for breast cancer cell survival across multiple subtypes, are immunogenic in DCIS and IBC

Authors

SE Sanborn, Providence

Document Type

Presentation

Publication Date

9-9-2022

Keywords

oregon; portland; chiles; genomics

Clinical Institute

Cancer

Department

Oncology

Comments

AACR Annual Meeting; 2022 September 9; Philadelphia, PA.

Recommended Citation

Sanborn, SE, "Candidate antigens for a ductal carcinoma in situ vaccine, essential for breast cancer cell survival across multiple subtypes, are immunogenic in DCIS and IBC" (2022). Articles, Abstracts, and Reports. 6987.
https://digitalcommons.providence.org/publications/6987